• SENSEX 73,257.62
    -341.05 (--0.46%)
  • BANKNIFTY 53,974.90
    -391.80 (--0.72%)
  • NSE
    1,766.00 1,640.25(%)
  • Reliance Industries
    1,160.50 1,152.30(%)
  • Piramal Pharma
    235.45 231.85(%)
  • Larsen & Toubro
    3,892.00 4,440.00(%)
  • Billionbrains
    189.95 227.00(%)
  • United Breweries
    1,316.00 1,845.90(%)
  • HDFC Bank
    687.15 1,017.90(%)
  • Cholaman.Inv.&Fn
    1,555.00 1,952.00(%)
  • Lenskart Solut.
    697.50 725.00(%)
  • HDFC AMC
    2,317.50 2,901.00(%)
  • Jubilant Ingrev.
    581.55 535.30(%)
  • Acutaas Chemical
    3,690.00 1,571.20(%)
  • One 97
    1,640.50 1,856.50(%)
  • Ola Electric
    37.44 51.84(%)
  • Sahajanand Medi
    478.00 347.50(%)
  • Swiggy
    183.05 174.30(%)
  • Bajaj Finance
    918.00 1,177.60(%)
  • Infosys
    1,103.50 980.30(%)
  • Patanjali Foods
    352.00 613.95(%)
  • Netweb Technol.
    4,490.00 5,810.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarti Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Aarti Group
  • BSE Code : 2975.0
  • ISIN : INE767A01016
402.25 23 (6.04%)
  • As on 28 Oct 2026 (EOD)

  • Today’s Low

    380.85

  • Today’s High

    404.80

  • Open

    381.00

  • Perv Close

    379.35

  • 52W Low

    318.95

  • 52W High

    534.00

Key Indicators

  • P/E(TTM)

    21.29

  • Mar.Cap (₹Cr.)

    3,671.34

  • Div & Yield %

    0.50

  • Book Value(₹)

    153.92

  • Debt-Equity Ratio

    6.04

  • AGM Date

    27-Oct-2026

  • EPS

    18.95

  • P/E Ratio

    21.29

Financials Ratios

  • Debt-Equity Ratio

    0.47

  • Mar.Cap (₹Cr.)

    3,671.34

  • RONW (%)

    13.87

  • ROCE (%)

    14.97

Score Board

  • Equity (₹ in Cr.)

    91.27

  • BV (₹)

    153.90

  • Sales( ₹ in Cr.)

    2,260.39

  • NP (in Cr.)

    169.22

  • NP Var(%)

    8.0

  • Div%

    20.0

  • CPS (₹)

    24.60

  • EPS (₹)

    18.50

  • Traded Value (₹ in Lakhs)

    3,681.83

  • 52 Week High

    534.00

  • 52 Week Low

    318.95

  • Price BSE

    403.0

  • Price NSE

    402.00

  • Market Capital( in Cr.)

    3,681.83

  • P/C Ratio

    16.40

  • P/E Ratio

    21.70

  • Price Vs.BV

    18.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,260.39 2,173.65 2,266.91 2,497.97 2,251.17 1,914.89
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,260.39 2,173.65 2,266.91 2,497.97 2,251.17 1,914.89
Other Income 2.59 13.57 4.18 2.23 4.77 9.69
Stock Adjustments -6.62 -22.00 -26.77 6.72 77.94 9.08
Total Income 2,256.36 2,165.22 2,244.32 2,506.92 2,333.88 1,933.66
EXPENDITURE :            
Raw Materials 1,424.24 1,376.63 1,476.42 1,723.25 1,558.47 1,148.99
Power and Fuel Cost 170.78 153.51 151.64 153.45 126.05 95.64
Employee Cost 85.03 73.88 70.20 64.30 57.17 55.60
Other Manufacturing Expenses 222.61 199.25 201.92 182.71 171.26 138.99
Selling and Administration Expenses 80.32 74.83 63.27 89.25 89.75 76.70
Miscellaneous Expenses 8.29 8.37 7.52 5.68 5.24 6.72
Employee Benefit Expenses 85.03 73.88 70.20 64.30 57.17 55.60
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,991.28 1,886.48 1,970.96 2,218.64 2,007.95 1,522.64
Operating Profit 265.09 278.74 273.36 288.28 325.94 411.02
Interest 28.14 32.20 33.21 36.18 23.05 25.71
Gross Profit 236.95 246.54 240.15 252.10 302.89 385.31
Depreciation 55.64 47.79 47.67 47.29 47.39 47.60
Profit Before Tax 181.31 198.75 192.48 204.81 255.50 337.71
Current Tax 7.23 37.94 49.60 53.25 65.50 84.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.85 3.50 1.00 -1.25 -5.00 -4.50
Reported Net Profit 169.22 157.31 141.88 152.81 195.00 257.71
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.17
Adjusted Net Profit 169.22 157.31 141.88 152.81 195.00 257.54
Adjustment below Net Profit -16.92 -15.73 -13.32 0.00 -51.64 -69.90
P & L Balance brought forward 1,126.48 1,052.31 947.13 818.86 704.26 565.52
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 18.25 67.41 23.38 24.54 28.76 49.07
P & L Balance carried down 1,260.53 1,126.48 1,052.31 947.13 818.86 704.26
Dividend 0.00 0.00 9.19 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 20.00 10.00 10.00 10.00 10.00 25.00
Dividend Per Share(Rs) 2.00 1.00 1.00 1.00 1.00 2.50
Earnings Per Share-Unit Curr 18.54 17.24 15.43 16.50 21.06 27.65
Earnings Per Share(Adj)-Unit Curr 18.54 17.24 15.43 16.50 21.06 27.65
Book Value 153.92 137.10 127.83 120.34 104.99 92.23
Book Value(Adj)-Unit Curr 153.92 137.10 127.83 120.34 104.99 92.23

Shareholding Pattern

  • Promoter Group

    54.07%

  • Public Share Holding

    45.93%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 8,571,669 9.39 8,571,669 7
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 38,118,254 41.76 38,118,254 28
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 2,661,305 2.92 2,661,305 6
Others 0 0.00 0 0
Sub Total 49,351,228 54.07 49,351,228 41
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 16 0.00 16 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,062,790 2.26 2,062,790 68
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 70,214 0.08 70,214 1
Mutual Funds / UTI 9,097,000 9.97 9,097,000 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 178,510 0.20 178,510 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 11,408,530 12.50 11,408,530 80
2] Non Institution
Bodies Corporate 984,294 1.08 984,293 366
Clearing Members 29,785 0.03 29,785 21
Directors of their Relatives 4,952,436 5.43 4,950,611 7
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 813,812 0.89 813,812 2,273
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 711,676 0.78 711,676 2,966
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,068,529 5.55 5,036,529 74
Individuals holding nominal share capital up to Rs. 1 lakh 16,705,843 18.30 16,182,078 134,073
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1 0.00 1 1
Others 1,001,336 1.10 1,001,336 5
Sub Total 30,510,242 33.43 29,952,651 139,828
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 91,270,000 100.00 90,712,409 139,949

Company Background

Aarti Drugs LtdPharmaceuticals - Indian - Bulk Drugs

  • Aarti Drugs Ltd
  • BSE Code : 2975.0
  • ISIN : INE767A01016

  • Incorporation Year

    1984

  • Registered Office

    Plot No N-198 MIDC Tarapur
    Pamtembhi Village Palghar Tal, Thane,
    Maharashtra-401506

  • Telephone

    91-22-24072249

  • FAX

    91-22-24073462/24070144

  • Chairman

    Chandrakant V. Gogri

  • Managing Director

    Prakash M Patil

  • Company Secretary

    Rushikesh V Deole

  • Auditor

    Gokhale & Sathe

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarti Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarti Drugs 403.40 2,262.98 2,260.39 21.48 11.64
Abbott India 25,488.50 7,217.19 6,929.05 33.54 43.78
Astrazeneca Phar 6,073.10 2,304.07 2,275.58 89.51 27.86
Glaxosmi. Pharma 2,488.75 3,932.76 3,790.20 39.76 58.17
Novartis India 1,847.40 393.10 354.33 46.65 15.94
Cipla 1,350.00 20,102.60 18,979.95 41.15 13.88
Bliss GVS Pharma 643.55 773.53 729.81 59.81 12.51
Amrutanjan Healt 490.45 520.13 502.55 26.27 24.16
Fermenta Biotec. 449.00 474.15 450.25 20.96 18.77
Guj. Themis Bio. 352.45 168.25 165.82 94.24 18.05
Ambalal Sarabhai 35.40 19.52 3.94 65.56 6.77